Taking a Stand for Patients
Who We Are
The Alliance for Transparent & Affordable Prescriptions (ATAP) is a coalition of patient and provider organizations functioning at both the state and national level who have joined together to address pharmacy benefit managers (PBMs) and their impact on prescription drug costs and patient access to affordable treatment.
On Dec. 4, Senators Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.) introduced new legislation to ensure that drug companies play by the rules of the Medicaid program. The bill is aimed at preventing drug companies from overcharging Medicaid, a practice that has been consistently costing taxpayers billions of dollars. While the legislation is an excellent indicator of future bipartisan cooperation on the issue of prescription drug affordability, much more needs to be done.
Express Scripts' new Flex formulary has been touted as an alternative to the rebate-based system, but who really benefits?
